[Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis].
Alexandra Olegovna KonradiN E ZvartauI E СhazovaYulia V ZhernakovaAletta Elisabeth SchutteMarkus P SchlaichPublished in: Terapevticheskii arkhiv (2021)
Russian physicians were the most aware of I1-IR agonists and tended to prescribe drugs of this class for hypertension management more often, and I1-IR agonist combination with ACEi was preferable compared to physician responders from other countries. Antihypertensive efficacy and metabolic effects were reported as the major benefits of I1-IR agonist therapy.